Pyrazinamide (PZA) is considered the pivot drug in all tuberculosis treatment regimens due to its particular action on the persistent forms of Mycobacterium tuberculosis However, no drug susceptibility test (DST) is considered sufficiently reliable for routine application. Although molecular tests are endorsed, their application is limited to known PZA resistance associated mutations. Microbiological DSTs for PZA have been restricted by technical limitations, especially the necessity for an acidic pH. Here, for the first time, MODS culture at neutral pH was evaluated using high PZA concentrations (400 and 800 μg/ml) to determine PZA susceptibility directly from sputum samples. Sputum samples were cultured with PZA for up to 21 days at 37°C....
AbstractAimPyrazinamide (PZA) is a first-line key agent in the effective treatment of tuberculosis (...
AbstractThe microscopic observation drug susceptibility assay (MODS) was evaluated to determine susc...
The continued use of pyrazinamide in the treatment of tuberculosis in the absence of a rapid, accura...
Pyrazinamide (PZA) is considered the pivot drug in all tuberculosis treatment regimens due to its pa...
Although pyrazinamide (PZA) is a key component of first- and second-line tuberculosis treatment regi...
Although pyrazinamide (PZA) is a key component of first- and second-line tuberculosis treatment regi...
AbstractThe microscopic observation drug susceptibility assay (MODS) was evaluated to determine susc...
CITATION: Demers, A.-M. et al. 2016. Direct susceptibility testing of Mycobacterium tuberculosis for...
AbstractPyrazinamide (PZA) is included in the 2016 World Health Organization multidrug-resistant tub...
Susceptibility testing of tuberculosis (TB) drugs on Mycobacterium tuberculosis is essential for the...
Introduction: Pyrazinamide (PZA) susceptibility testing plays a critical role in determining the app...
Pyrazinamide (PZA) is an important first-line anti-tuberculosis drug. But PZA susceptibility test is...
Background: The main mechanism of resistance to PZA in Mycobacterium tuberculosis relies on mutation...
Pyrazinamide (PZA) susceptibility testing in Mycobacterium tuberculosis (Mtb) is a current area of d...
Pyrazinamide (PZA) is a key antituberculosis drug, yet no rapid susceptibility test is commercially ...
AbstractAimPyrazinamide (PZA) is a first-line key agent in the effective treatment of tuberculosis (...
AbstractThe microscopic observation drug susceptibility assay (MODS) was evaluated to determine susc...
The continued use of pyrazinamide in the treatment of tuberculosis in the absence of a rapid, accura...
Pyrazinamide (PZA) is considered the pivot drug in all tuberculosis treatment regimens due to its pa...
Although pyrazinamide (PZA) is a key component of first- and second-line tuberculosis treatment regi...
Although pyrazinamide (PZA) is a key component of first- and second-line tuberculosis treatment regi...
AbstractThe microscopic observation drug susceptibility assay (MODS) was evaluated to determine susc...
CITATION: Demers, A.-M. et al. 2016. Direct susceptibility testing of Mycobacterium tuberculosis for...
AbstractPyrazinamide (PZA) is included in the 2016 World Health Organization multidrug-resistant tub...
Susceptibility testing of tuberculosis (TB) drugs on Mycobacterium tuberculosis is essential for the...
Introduction: Pyrazinamide (PZA) susceptibility testing plays a critical role in determining the app...
Pyrazinamide (PZA) is an important first-line anti-tuberculosis drug. But PZA susceptibility test is...
Background: The main mechanism of resistance to PZA in Mycobacterium tuberculosis relies on mutation...
Pyrazinamide (PZA) susceptibility testing in Mycobacterium tuberculosis (Mtb) is a current area of d...
Pyrazinamide (PZA) is a key antituberculosis drug, yet no rapid susceptibility test is commercially ...
AbstractAimPyrazinamide (PZA) is a first-line key agent in the effective treatment of tuberculosis (...
AbstractThe microscopic observation drug susceptibility assay (MODS) was evaluated to determine susc...
The continued use of pyrazinamide in the treatment of tuberculosis in the absence of a rapid, accura...